BRIDGEBIO PHARMA INC. - COMMON STOCK
25,23
04-октября-24 14:59:59
15 мин. задержка
Акции
-0,40
-1,56%
Сегодняшний диапазон
25,12 - 26,05
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
03 июн 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
24 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
14 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
13 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
02 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
02 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 апр 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20 мар 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
05 мар 2024 22:53:56 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
04 мар 2024 15:17:36 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
04 мар 2024 01:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
22 фев 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
07 фев 2024 06:34:22 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 фев 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
05 фев 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
18 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire